AAM White Paper on Shortages

Generic medicines are the backbone of the U.S. prescription drug market, supplying more than 9 out of every 10 prescriptions. And the availability of generic medicines overall is remarkably stable – even during challenges such as the COVID-19 pandemic.

Nonetheless, drug shortages, which hit crisis proportions between 2010 and 2011, can be a challenge for manufacturers, providers, and patients. Due to aggressive efforts by industry and the Food and Drug Administration (FDA), the incidence of shortages has declined, but recent reports suggest a rise in shortages in 2023.

Read Report


Share Your Voice

To help raise awareness of the essentialness of generic medicines to patients and our healthcare system, join our industry's 4GRxANTED campaign. The #4GRxANTED campaign asks people to  record a video or share a story explaining who or what in their lives they take for granted but shouldn’t and post it on social media. For every video created, liked or shared with the hashtag #4GRxANTED, the generics industry will donate medicines to Direct Relief, a humanitarian aid organization that provides medical assistance to people affected by poverty or emergencies.

4GRxANTED Share Your Story



Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.